MetaADEDB 2.0 @ LMMD
Ruxolitinib phosphate
(JFMWPOCYMYGEDM-XFULWGLBSA-N)
Structure
SMILES
OP(=O)(O)O.N#CC[C@@H](n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1
Molecular Formula:
C17H21N6O4P
Molecular Weight:
404.360
Log P:
2.5378
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
4
TPSA:
170.75
CAS Number(s):
1092939-17-7
Synonym(s)
1.
Ruxolitinib phosphate
External Link(s)
PubChem Compound25127112
BindingDB50391992
ChEBI66917
CHEMBLCHEMBL1795071
KEGGdr:D09960
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 611
Canada Vigilance: 19
Canada Vigilance
US FAERS
2Drug dose omissionFAERS: 504US FAERS
3PneumoniaFAERS: 480
Canada Vigilance: 5
Canada Vigilance
US FAERS
4MyelofibrosisFAERS: 412
Canada Vigilance: 4
Canada Vigilance
US FAERS
5SplenomegalyFAERS: 380
Canada Vigilance: 17
Canada Vigilance
US FAERS
6HeadacheFAERS: 355
Canada Vigilance: 11
Canada Vigilance
US FAERS
7MalaiseFAERS: 336
Canada Vigilance: 18
Canada Vigilance
US FAERS
8AstheniaFAERS: 315
Canada Vigilance: 13
Canada Vigilance
US FAERS
9DizzinessFAERS: 300
Canada Vigilance: 8
Canada Vigilance
US FAERS
10Inappropriate schedule of product administrationFAERS: 280
Canada Vigilance: 2
Canada Vigilance
US FAERS
11ThrombocytopeniaFAERS: 266
Canada Vigilance: 3
Canada Vigilance
US FAERS
12Blood count abnormalFAERS: 246
Canada Vigilance: 3
Canada Vigilance
US FAERS
13NauseaFAERS: 213
Canada Vigilance: 4
Canada Vigilance
US FAERS
14Drug ineffectiveFAERS: 196
Canada Vigilance: 19
Canada Vigilance
US FAERS
15InfectionFAERS: 196
Canada Vigilance: 3
Canada Vigilance
US FAERS
16PruritusFAERS: 192
Canada Vigilance: 6
Canada Vigilance
US FAERS
17Product dose omissionFAERS: 191US FAERS
18PainFAERS: 176
Canada Vigilance: 10
Canada Vigilance
US FAERS
19Inappropriate schedule of drug administrationFAERS: 172US FAERS
20Abdominal PainFAERS: 168
Canada Vigilance: 10
Canada Vigilance
US FAERS
21Platelet count abnormalFAERS: 166
Canada Vigilance: 3
Canada Vigilance
US FAERS
22White blood cell count decreasedFAERS: 151
Canada Vigilance: 8
Canada Vigilance
US FAERS
23Urinary tract infectionFAERS: 138
Canada Vigilance: 4
Canada Vigilance
US FAERS
24NasopharyngitisFAERS: 137
Canada Vigilance: 3
Canada Vigilance
US FAERS
25EpistaxisFAERS: 134
Canada Vigilance: 6
Canada Vigilance
US FAERS
26Memory impairmentFAERS: 129
Canada Vigilance: 3
Canada Vigilance
US FAERS
27SepsisFAERS: 129
Canada Vigilance: 1
Canada Vigilance
US FAERS
28Incorrect dose administeredFAERS: 126
Canada Vigilance: 1
Canada Vigilance
US FAERS
29Abdominal discomfortFAERS: 124
Canada Vigilance: 2
Canada Vigilance
US FAERS
30ArthralgiaFAERS: 124
Canada Vigilance: 4
Canada Vigilance
US FAERS
31ConstipationFAERS: 123
Canada Vigilance: 6
Canada Vigilance
US FAERS
32VomitingFAERS: 114
Canada Vigilance: 1
Canada Vigilance
US FAERS
33Peripheral swellingFAERS: 112
Canada Vigilance: 6
Canada Vigilance
US FAERS
34Weight decreasedFAERS: 111
Canada Vigilance: 7
Canada Vigilance
US FAERS
35Product use in unapproved indicationFAERS: 109US FAERS
36White blood cell count abnormalFAERS: 109
Canada Vigilance: 1
Canada Vigilance
US FAERS
37InfluenzaFAERS: 105
Canada Vigilance: 3
Canada Vigilance
US FAERS
38Bone painFAERS: 97
Canada Vigilance: 3
Canada Vigilance
US FAERS
39TuberculosisFAERS: 97US FAERS
40Disease ProgressionFAERS: 96US FAERS
41Back PainFAERS: 92
Canada Vigilance: 3
Canada Vigilance
US FAERS
42Night sweatsFAERS: 92
Canada Vigilance: 2
Canada Vigilance
US FAERS
43PancytopeniaFAERS: 92US FAERS
44FlatulenceFAERS: 90
Canada Vigilance: 3
Canada Vigilance
US FAERS
45Feeling abnormalFAERS: 87
Canada Vigilance: 6
Canada Vigilance
US FAERS
46General physical health deteriorationFAERS: 86
Canada Vigilance: 2
Canada Vigilance
US FAERS
47Blood lactate dehydrogenase increasedFAERS: 79US FAERS
48Primary MyelofibrosisFAERS: 75US FAERS
49Cerebrovascular accidentFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
50MyalgiaFAERS: 72
Canada Vigilance: 1
Canada Vigilance
US FAERS
51CytopeniaFAERS: 71
Canada Vigilance: 1
Canada Vigilance
US FAERS
52StomatitisFAERS: 70
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Blast cell count increasedFAERS: 68
Canada Vigilance: 3
Canada Vigilance
US FAERS
54Blood creatinine increasedFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
55SomnolenceFAERS: 67
Canada Vigilance: 5
Canada Vigilance
US FAERS
56Product use issueFAERS: 66US FAERS
57ThrombosisFAERS: 66
Canada Vigilance: 2
Canada Vigilance
US FAERS
58Basal cell carcinomaFAERS: 65
Canada Vigilance: 1
Canada Vigilance
US FAERS
59Chest PainFAERS: 62
Canada Vigilance: 2
Canada Vigilance
US FAERS
60AlopeciaFAERS: 61US FAERS
61Blood lactate dehydrogenase abnormalFAERS: 61US FAERS
62Squamous cell carcinomaFAERS: 61US FAERS
63Myocardial InfarctionFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
64NeutropeniaFAERS: 60
Canada Vigilance: 2
Canada Vigilance
US FAERS
65BronchitisFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Respiratory FailureFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
67ChillsFAERS: 55
Canada Vigilance: 3
Canada Vigilance
US FAERS
68Oropharyngeal painFAERS: 53US FAERS
69Toxicity to various agentsFAERS: 51US FAERS
70Wrong technique in product usage processFAERS: 51
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Skin lesionFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
72HypotensionFAERS: 49US FAERS
73Therapeutic response unexpectedFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
74HaematotoxicityFAERS: 47US FAERS
75LeukocytosisFAERS: 47US FAERS
76Blast cells presentFAERS: 45US FAERS
77Blood alkaline phosphatase increasedFAERS: 45US FAERS
78DehydrationFAERS: 44US FAERS
79Pulmonary EmbolismFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Blood potassium increasedFAERS: 43US FAERS
81Concomitant disease aggravatedFAERS: 43US FAERS
82LeukopeniaFAERS: 43US FAERS
83Aspartate Aminotransferase IncreasedFAERS: 42US FAERS
84GoutFAERS: 42
Canada Vigilance: 3
Canada Vigilance
US FAERS
85ErythemaFAERS: 40
Canada Vigilance: 5
Canada Vigilance
US FAERS
86SinusitisFAERS: 40US FAERS
87Gamma-Glutamyltransferase IncreasedFAERS: 38US FAERS
88Alanine Aminotransferase IncreasedFAERS: 36US FAERS
89AscitesFAERS: 36US FAERS
90CellulitisFAERS: 36US FAERS
91No adverse eventFAERS: 36US FAERS
92Acute kidney injuryFAERS: 35US FAERS
93DysuriaFAERS: 34
Canada Vigilance: 2
Canada Vigilance
US FAERS
94AcneFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
95AnxietyFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
96Joint swellingFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Septic ShockFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
98Therapy non-responderFAERS: 32
Canada Vigilance: 4
Canada Vigilance
US FAERS
99Depressed moodFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
100Full blood count decreasedFAERS: 31
Canada Vigilance: 6
Canada Vigilance
US FAERS
101DyspepsiaFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
102HepatomegalyFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
103PalpitationsFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
104Pulmonary HypertensionFAERS: 30US FAERS
105Visual ImpairmentFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
106AmnesiaFAERS: 29US FAERS
107Atrial FibrillationFAERS: 28US FAERS
108CystitisFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
109Dry skinFAERS: 28US FAERS
110InflammationFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Neutrophil count decreasedFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Blood erythropoietin abnormalFAERS: 27US FAERS
113Medication ErrorFAERS: 27US FAERS
114SyncopeFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
115TremorFAERS: 27US FAERS
116HypersensitivityFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
117Increased tendency to bruiseFAERS: 26US FAERS
118Lymphocyte count decreasedFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
119MYELODYSPLASTIC SYNDROMEFAERS: 26US FAERS
120ArthritisFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
121Blood cholesterol increasedFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
122DiverticulitisFAERS: 25US FAERS
123Musculoskeletal PainFAERS: 25US FAERS
124Squamous cell carcinoma of skinFAERS: 25US FAERS
125Burning sensationFAERS: 24US FAERS
126DementiaFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
127ThrombocytosisFAERS: 24US FAERS
128Blood glucose increasedFAERS: 23US FAERS
129Disease risk factorFAERS: 23US FAERS
130DysgeusiaFAERS: 23US FAERS
131Intentional product misuseFAERS: 23US FAERS
132VertigoFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
133DysphoniaFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
134Diabetes MellitusFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
135LymphadenopathyFAERS: 21US FAERS
136Skin UlcerFAERS: 21US FAERS
137Blood urea increasedFAERS: 20US FAERS
138SwellingFAERS: 20
Canada Vigilance: 1
Canada Vigilance
US FAERS
139Feeling ColdFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
140HungerFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
141Limb injuryFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
142NephrolithiasisFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Cerebral InfarctionFAERS: 17US FAERS
144Chest discomfortFAERS: 17US FAERS
145Drug ineffective for unapproved indicationFAERS: 17US FAERS
146IleusFAERS: 17US FAERS
147Joint injuryFAERS: 17US FAERS
148Lower respiratory tract infectionFAERS: 17US FAERS
149LymphomaFAERS: 17US FAERS
150Malignant neoplasm progressionFAERS: 17US FAERS
151PetechiaeFAERS: 17US FAERS
152PneumonitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Splenic InfarctionFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
154TinnitusFAERS: 17US FAERS
155AphasiaFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
156Cardiac ArrestFAERS: 16US FAERS
157CholelithiasisFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Diffuse Large B-Cell LymphomaFAERS: 16US FAERS
159Musculoskeletal chest painFAERS: 16US FAERS
160Product administered to patient of inappropriate ageFAERS: 16US FAERS
161Adverse eventFAERS: 15US FAERS
162Angina PectorisFAERS: 15US FAERS
163Blood iron decreasedFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
164Eye painFAERS: 15US FAERS
165GastritisFAERS: 15US FAERS
166GastroenteritisFAERS: 15US FAERS
167Neck PainFAERS: 15US FAERS
168Portal HypertensionFAERS: 15US FAERS
169Splenic RuptureFAERS: 15US FAERS
170TachycardiaFAERS: 15US FAERS
171AsthmaFAERS: 14US FAERS
172Decreased immune responsivenessFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
173Full blood count increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
174LethargyFAERS: 14US FAERS
175NeuralgiaFAERS: 14US FAERS
176Pericardial effusionFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
177Portal Vein ThrombosisFAERS: 14US FAERS
178Product physical issueFAERS: 14US FAERS
179Productive CoughFAERS: 14US FAERS
180Terminal stateFAERS: 14
Canada Vigilance: 3
Canada Vigilance
US FAERS
181jaundiceFAERS: 14US FAERS
182Drug administered to patient of inappropriate ageFAERS: 13US FAERS
183Drug administration errorFAERS: 13US FAERS
184Drug effect incompleteFAERS: 13US FAERS
185Full blood count abnormalFAERS: 13US FAERS
186Head discomfortFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Intentional product use issueFAERS: 13US FAERS
188Transaminases increasedFAERS: 13US FAERS
189ChromaturiaFAERS: 12US FAERS
190Clostridium difficile infectionFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
191Deep Vein ThrombosisFAERS: 12US FAERS
192DiscomfortFAERS: 12US FAERS
193DisorientationFAERS: 12US FAERS
194Febrile NeutropeniaFAERS: 12US FAERS
195HepatosplenomegalyFAERS: 12US FAERS
196ImmunosuppressionFAERS: 12US FAERS
197Poor quality sleepFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
198Rash erythematousFAERS: 12US FAERS
199Skin irritationFAERS: 12US FAERS
200Tooth InfectionFAERS: 12US FAERS
201Blood glucose decreasedFAERS: 11US FAERS
202Blood product transfusion dependentFAERS: 11US FAERS
203Bowen's DiseaseFAERS: 11US FAERS
204DeafnessFAERS: 11US FAERS
205Eye InfectionFAERS: 11US FAERS
206FractureFAERS: 11US FAERS
207Gastric ulcerFAERS: 11US FAERS
208General physical condition abnormalFAERS: 11US FAERS
209HypersomniaFAERS: 11US FAERS
210PallorFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
211PolyneuropathyFAERS: 11US FAERS
212Respiratory distressFAERS: 11US FAERS
213SplenectomyFAERS: 11US FAERS
214Sudden deathFAERS: 11US FAERS
215TransplantFAERS: 11US FAERS
216UrticariaFAERS: 11US FAERS
217Ankle FractureFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
218Aortic AneurysmFAERS: 10US FAERS
219Blood iron increasedFAERS: 10US FAERS
220Blood triglycerides increasedFAERS: 10US FAERS
221CachexiaFAERS: 10US FAERS
222Clostridium difficile colitisFAERS: 10US FAERS
223Cytokine stormFAERS: 10US FAERS
224Dental cariesFAERS: 10US FAERS
225DiplopiaFAERS: 10US FAERS
226Disease recurrenceFAERS: 10US FAERS
227HypoxiaFAERS: 10US FAERS
228Limb discomfortFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
229Musculoskeletal stiffnessFAERS: 10US FAERS
230OnychoclasisFAERS: 10US FAERS
231Pancreatic carcinomaFAERS: 10US FAERS
232PeritonitisFAERS: 10US FAERS
233Stem cell transplantFAERS: 10US FAERS
234Amylase increasedFAERS: 9US FAERS
235AppendicitisFAERS: 9US FAERS
236Blood sodium decreasedFAERS: 9US FAERS
237Concomitant disease progressionFAERS: 9US FAERS
238DeliriumFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
239Dengue FeverFAERS: 9US FAERS
240Disseminated Intravascular CoagulationFAERS: 9US FAERS
241Early satietyFAERS: 9US FAERS
242Electrolyte imbalanceFAERS: 9US FAERS
243EnterocolitisFAERS: 9US FAERS
244Escherichia urinary tract infectionFAERS: 9US FAERS
245Gait inabilityFAERS: 9US FAERS
246Hepatitis BFAERS: 9US FAERS
247Intestinal ObstructionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Iron OverloadFAERS: 9US FAERS
249Irritable Bowel SyndromeFAERS: 9US FAERS
250Mental impairmentFAERS: 9US FAERS
251NervousnessFAERS: 9US FAERS
252Oral painFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
253Post procedural complicationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
254Rheumatoid ArthritisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
255StressFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
256AbscessFAERS: 8US FAERS
257Acute respiratory failureFAERS: 8US FAERS
258ArthropathyFAERS: 8US FAERS
259Basophil percentage increasedFAERS: 8US FAERS
260Blood urine presentFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
261Bronchopulmonary AspergillosisFAERS: 8US FAERS
262CataractFAERS: 8US FAERS
263CholangitisFAERS: 8US FAERS
264ColitisFAERS: 8US FAERS
265CryingFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
266Ear discomfortFAERS: 8US FAERS
267EndocarditisFAERS: 8US FAERS
268Food PoisoningFAERS: 8US FAERS
269Gastrointestinal infectionFAERS: 8US FAERS
270HepatitisFAERS: 8US FAERS
271HepatotoxicityFAERS: 8US FAERS
272LacerationFAERS: 8US FAERS
273OverdoseFAERS: 8US FAERS
274Protein total decreasedFAERS: 8US FAERS
275Pulmonary congestionFAERS: 8US FAERS
276Restless Legs SyndromeFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
277ToothacheFAERS: 8US FAERS
278Wrong technique in drug usage processFAERS: 8US FAERS
279furuncleFAERS: 8US FAERS
280Acute Coronary SyndromeFAERS: 7US FAERS
281AgitationFAERS: 7US FAERS
282Altered state of consciousnessFAERS: 7US FAERS
283Back disorderFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
284BlindnessFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
285CardiomegalyFAERS: 7US FAERS
286Cholecystitis infectiveFAERS: 7US FAERS
287DermatitisFAERS: 7US FAERS
288Disease complicationFAERS: 7US FAERS
289Drug prescribing errorFAERS: 7US FAERS
290EncephalitisFAERS: 7US FAERS
291Flank PainFAERS: 7US FAERS
292Gastroenteritis norovirusFAERS: 7US FAERS
293Gastrointestinal ulcerFAERS: 7US FAERS
294GlaucomaFAERS: 7US FAERS
295Hospice CareFAERS: 7US FAERS
296Large intestine perforationFAERS: 7US FAERS
297LaryngitisFAERS: 7US FAERS
298Lip swellingFAERS: 7US FAERS
299LymphopeniaFAERS: 7US FAERS
300MeningitisFAERS: 7US FAERS
301Muscle strainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
302Musculoskeletal discomfortFAERS: 7US FAERS
303NoduleFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
304OsteomyelitisFAERS: 7US FAERS
305PancreatitisFAERS: 7US FAERS
306Product prescribing errorFAERS: 7US FAERS
307Product quality issueFAERS: 7US FAERS
308Product taste abnormalFAERS: 7US FAERS
309Pulmonary FibrosisFAERS: 7US FAERS
310Respiratory arrestFAERS: 7US FAERS
311RestlessnessFAERS: 7US FAERS
312Secretion dischargeFAERS: 7US FAERS
313SplenitisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
314UlcerFAERS: 7US FAERS
315Unevaluable eventFAERS: 7US FAERS
316Viral upper respiratory tract infectionFAERS: 7US FAERS
317AbasiaFAERS: 6US FAERS
318Actinic keratosisFAERS: 6US FAERS
319AtaxiaFAERS: 6US FAERS
320BicytopeniaFAERS: 6US FAERS
321Bladder painFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
322Blood blisterFAERS: 6US FAERS
323Blood triglycerides abnormalFAERS: 6US FAERS
324Bone marrow reticulin fibrosisFAERS: 6US FAERS
325BradycardiaFAERS: 6US FAERS
326Drug resistanceFAERS: 6US FAERS
327EcchymosisFAERS: 6US FAERS
328EmbolismFAERS: 6US FAERS
329EpilepsyFAERS: 6US FAERS
330Escherichia infectionFAERS: 6US FAERS
331Escherichia sepsisFAERS: 6US FAERS
332Facial paralysisFAERS: 6US FAERS
333FibrosisFAERS: 6US FAERS
334Gastric DilatationFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
335GingivitisFAERS: 6US FAERS
336Guillain-Barre SyndromeFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
337HerniaFAERS: 6US FAERS
338HyperkeratosisFAERS: 6US FAERS
339Iron deficiencyFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
340Metamyelocyte count increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
341NocturiaFAERS: 6US FAERS
342OsteoporosisFAERS: 6US FAERS
343Respiratory tract congestionFAERS: 6US FAERS
344Subcutaneous AbscessFAERS: 6US FAERS
345Therapeutic product effect incompleteFAERS: 6US FAERS
346Therapy cessationFAERS: 6US FAERS
347Therapy changeFAERS: 6US FAERS
348Therapy partial responderFAERS: 6US FAERS
349Accidental overdoseFAERS: 5US FAERS
350Acute myocardial infarctionFAERS: 5US FAERS
351Arthropod biteFAERS: 5US FAERS
352Cold sweatFAERS: 5US FAERS
353Creatinine renal clearance decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
354Cytomegalovirus hepatitisFAERS: 5US FAERS
355Dermatitis acneiformFAERS: 5US FAERS
356Drug withdrawal syndromeFAERS: 5US FAERS
357EructationFAERS: 5US FAERS
358Facial PainFAERS: 5US FAERS
359Graft versus host disease in liverFAERS: 5US FAERS
360GranulomaFAERS: 5US FAERS
361HemiparesisFAERS: 5US FAERS
362Histiocytosis haematophagicFAERS: 5US FAERS
363Intestinal PerforationFAERS: 5US FAERS
364LymphocytosisFAERS: 5US FAERS
365Malignant transformationFAERS: 5US FAERS
366Myelocyte count increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
367OnychomycosisFAERS: 5US FAERS
368Oral candidiasisFAERS: 5US FAERS
369Oral fungal infectionFAERS: 5US FAERS
370Oral mucosal eruptionFAERS: 5US FAERS
371Paranasal sinus discomfortFAERS: 5US FAERS
372Performance status decreasedFAERS: 5US FAERS
373Peripheral arterial occlusive diseaseFAERS: 5US FAERS
374PhlebitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
375Platelet TransfusionFAERS: 5US FAERS
376PolyarthritisFAERS: 5US FAERS
377Poor peripheral circulationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
378Quality of life decreasedFAERS: 5US FAERS
379Rebound effectFAERS: 5US FAERS
380Renal cystFAERS: 5US FAERS
381ScabFAERS: 5US FAERS
382Throat irritationFAERS: 5US FAERS
383Tongue blisteringFAERS: 5US FAERS
384Upper-airway cough syndromeFAERS: 5US FAERS
385Urinary IncontinenceFAERS: 5US FAERS
386Urinary RetentionFAERS: 5US FAERS
387WheezingFAERS: 5US FAERS
388Wound InfectionFAERS: 5US FAERS
389treatment failureFAERS: 5US FAERS
390AdenocarcinomaFAERS: 4US FAERS
391AgeusiaFAERS: 4US FAERS
392Anal abscessFAERS: 4US FAERS
393AnisocytosisFAERS: 4US FAERS
394AnuriaFAERS: 4US FAERS
395ApathyFAERS: 4US FAERS
396AtelectasisFAERS: 4US FAERS
397Atrioventricular BlockFAERS: 4US FAERS
398Bladder NeoplasmFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
399Blood albumin decreasedFAERS: 4US FAERS
400Blood cholesterol abnormalFAERS: 4US FAERS
401Blood glucose fluctuationFAERS: 4US FAERS
402Blood potassium abnormalFAERS: 4US FAERS
403Body temperature fluctuationFAERS: 4US FAERS
404Bone density abnormalFAERS: 4US FAERS
405Bone lesionFAERS: 4US FAERS
406Bone marrow myelogram abnormalFAERS: 4US FAERS
407Cardiac TamponadeFAERS: 4US FAERS
408Cardiac dysfunctionFAERS: 4US FAERS
409Cerebral atrophyFAERS: 4US FAERS
410CholecystitisFAERS: 4US FAERS
411Cytomegalovirus chorioretinitisFAERS: 4US FAERS
412Diabetic NephropathyFAERS: 4US FAERS
413Drug dispensing errorFAERS: 4US FAERS
414Dry gangreneFAERS: 4US FAERS
415DysarthriaFAERS: 4US FAERS
416Expired product administeredFAERS: 4US FAERS
417Extra dose administeredFAERS: 4US FAERS
418Gastrointestinal PainFAERS: 4US FAERS
419Genital HerpesFAERS: 4US FAERS
420Graft versus host disease in lungFAERS: 4US FAERS
421Hepatitis CFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
422HordeolumFAERS: 4US FAERS
423Hypertensive crisisFAERS: 4US FAERS
424HyperthyroidismFAERS: 4US FAERS
425HypophagiaFAERS: 4US FAERS
426HypothyroidismFAERS: 4US FAERS
427Incorrect product formulation administeredFAERS: 4US FAERS
428InfarctionFAERS: 4US FAERS
429Janus kinase 2 mutationFAERS: 4US FAERS
430Joint stiffnessFAERS: 4US FAERS
431LeukoencephalopathyFAERS: 4US FAERS
432Liver AbscessFAERS: 4US FAERS
433LymphadenitisFAERS: 4US FAERS
434MalnutritionFAERS: 4US FAERS
435Monocyte count decreasedFAERS: 4US FAERS
436MyositisFAERS: 4US FAERS
437NephritisFAERS: 4US FAERS
438Neutropenic sepsisFAERS: 4US FAERS
439Neutrophil percentage increasedFAERS: 4US FAERS
440Pain of skinFAERS: 4US FAERS
441PharyngitisFAERS: 4US FAERS
442PneumothoraxFAERS: 4US FAERS
443PoikilocytosisFAERS: 4US FAERS
444Post procedural infectionFAERS: 4US FAERS
445Product packaging quantity issueFAERS: 4US FAERS
446Product storage errorFAERS: 4US FAERS
447Product use complaintFAERS: 4US FAERS
448Pulmonary thrombosisFAERS: 4US FAERS
449PyelonephritisFAERS: 4US FAERS
450RalesFAERS: 4US FAERS
451Renal painFAERS: 4US FAERS
452Retinal DetachmentFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
453RhinitisFAERS: 4US FAERS
454SclerodermaFAERS: 4US FAERS
455Skin reactionFAERS: 4US FAERS
456Stent malfunctionFAERS: 4US FAERS
457Tooth ExtractionFAERS: 4US FAERS
458Unresponsive to stimuliFAERS: 4US FAERS
459Upper respiratory tract inflammationFAERS: 4US FAERS
460Wound ComplicationFAERS: 4US FAERS
461nervous system disorderFAERS: 4US FAERS
462prostatitisFAERS: 4US FAERS
463Abdominal InfectionFAERS: 3US FAERS
464AcanthosisFAERS: 3US FAERS
465Accidental exposure to productFAERS: 3US FAERS
466Activities of daily living impairedFAERS: 3US FAERS
467AphoniaFAERS: 3US FAERS
468Apparent deathFAERS: 3US FAERS
469Atypical pneumoniaFAERS: 3US FAERS
470BK virus infectionFAERS: 3US FAERS
471Bacterial sepsisFAERS: 3US FAERS
472Bacterial test positiveFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
473Bilirubin conjugated increasedFAERS: 3US FAERS
474Blood creatine increasedFAERS: 3US FAERS
475Blood creatine phosphokinase increasedFAERS: 3US FAERS
476Blood fibrinogen decreasedFAERS: 3US FAERS
477Blood glucose abnormalFAERS: 3US FAERS
478Blood potassium decreasedFAERS: 3US FAERS
479BursitisFAERS: 3US FAERS
480Catheter site indurationFAERS: 3US FAERS
481Catheter site painFAERS: 3US FAERS
482Cell marker increasedFAERS: 3US FAERS
483Cerebral ThrombosisFAERS: 3US FAERS
484CholestasisFAERS: 3US FAERS
485ConjunctivitisFAERS: 3US FAERS
486Coronary Artery DiseaseFAERS: 3US FAERS
487Device related sepsisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
488DysgraphiaFAERS: 3US FAERS
489Ear congestionFAERS: 3US FAERS
490Endodontic procedureFAERS: 3US FAERS
491EosinophiliaFAERS: 3US FAERS
492Erythroblast count increasedFAERS: 3US FAERS
493Exfoliative rashFAERS: 3US FAERS
494Eye irritationFAERS: 3US FAERS
495Failure to ThriveFAERS: 3US FAERS
496Febrile infectionFAERS: 3US FAERS
497Feeling jitteryFAERS: 3US FAERS
498Fluid overloadFAERS: 3US FAERS
499FlushingFAERS: 3US FAERS
500FolliculitisFAERS: 3US FAERS
501Gastric infectionFAERS: 3US FAERS
502Gastrointestinal carcinomaFAERS: 3US FAERS
503GlossitisFAERS: 3US FAERS
504HemiplegiaFAERS: 3US FAERS
505Hepatic EncephalopathyFAERS: 3US FAERS
506Hepatic InfectionFAERS: 3US FAERS
507Hepatitis EFAERS: 3US FAERS
508HidradenitisFAERS: 3US FAERS
509HyperphagiaFAERS: 3US FAERS
510HypersplenismFAERS: 3US FAERS
511HypokinesiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
512IncontinenceFAERS: 3US FAERS
513Intestinal infarctionFAERS: 3US FAERS
514JC virus infectionFAERS: 3US FAERS
515Lipase increasedFAERS: 3US FAERS
516Lymph Node TuberculosisFAERS: 3US FAERS
517Lymphocyte count increasedFAERS: 3US FAERS
518Lymphocyte percentage decreasedFAERS: 3US FAERS
519Macular degenerationFAERS: 3US FAERS
520Mallory-Weiss SyndromeFAERS: 3US FAERS
521MastitisFAERS: 3US FAERS
522Meniscus injuryFAERS: 3US FAERS
523Mental status changesFAERS: 3US FAERS
524Metabolic function test abnormalFAERS: 3US FAERS
525MetastasisFAERS: 3US FAERS
526MonoplegiaFAERS: 3US FAERS
527Mood swingsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
528Multiple System AtrophyFAERS: 3US FAERS
529Muscle FatigueFAERS: 3US FAERS
530Myeloblast percentage increasedFAERS: 3US FAERS
531Nasal discomfortFAERS: 3US FAERS
532NecrosisFAERS: 3US FAERS
533Noninfective gingivitisFAERS: 3US FAERS
534Nonspecific reactionFAERS: 3US FAERS
535ObstructionFAERS: 3US FAERS
536Oropharyngeal discomfortFAERS: 3US FAERS
537OsteolysisFAERS: 3US FAERS
538PanniculitisFAERS: 3US FAERS
539Peptic UlcerFAERS: 3US FAERS
540PericarditisFAERS: 3US FAERS
541PlasmacytomaFAERS: 3US FAERS
542PleurisyFAERS: 3US FAERS
543Precancerous skin lesionFAERS: 3US FAERS
544Product dispensing errorFAERS: 3US FAERS
545Protein total increasedFAERS: 3US FAERS
546ProteinuriaFAERS: 3US FAERS
547Psychiatric symptomFAERS: 3US FAERS
548Pulmonary sepsisFAERS: 3US FAERS
549Red blood cell elliptocytes presentFAERS: 3US FAERS
550Reticulocyte count increasedFAERS: 3US FAERS
551RosaceaFAERS: 3US FAERS
552SciaticaFAERS: 3US FAERS
553Sebaceous hyperplasiaFAERS: 3US FAERS
554Sinus ArrhythmiaFAERS: 3US FAERS
555Sinus headacheFAERS: 3US FAERS
556Skin IndurationFAERS: 3US FAERS
557Skin PapillomaFAERS: 3US FAERS
558SneezingFAERS: 3US FAERS
559Status EpilepticusFAERS: 3US FAERS
560Tinea PedisFAERS: 3US FAERS
561TonsillitisFAERS: 3US FAERS
562Tooth LossFAERS: 3US FAERS
563Tympanic Membrane PerforationFAERS: 3US FAERS
564VasculitisFAERS: 3US FAERS
565Vitreous floatersFAERS: 3US FAERS
566leiomyosarcomaFAERS: 3US FAERS
567Abnormal weight gainFAERS: 2US FAERS
568AngerFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
569AnosmiaFAERS: 2US FAERS
570AphagiaFAERS: 2US FAERS
571Atrial FlutterFAERS: 2US FAERS
572BedriddenFAERS: 2US FAERS
573Benign Prostatic HyperplasiaFAERS: 2US FAERS
574Bladder discomfortFAERS: 2US FAERS
575Blast cell count decreasedFAERS: 2US FAERS
576Blood albumin increasedFAERS: 2US FAERS
577Blood bilirubin unconjugated increasedFAERS: 2US FAERS
578Blood cholinesterase decreasedFAERS: 2US FAERS
579Blood lactate dehydrogenaseFAERS: 2US FAERS
580Blood magnesium increasedFAERS: 2US FAERS
581Blood sodium abnormalFAERS: 2US FAERS
582Blood viscosity decreasedFAERS: 2US FAERS
583Bone TuberculosisFAERS: 2US FAERS
584Bowel movement irregularityFAERS: 2US FAERS
585Brain AbscessFAERS: 2US FAERS
586BronchiolitisFAERS: 2US FAERS
587Cataract operationFAERS: 2US FAERS
588Cerebral ventricular ruptureFAERS: 2US FAERS
589ChokingFAERS: 2US FAERS
590ClumsinessFAERS: 2US FAERS
591Completed SuicideFAERS: 2US FAERS
592Compression fractureFAERS: 2US FAERS
593Critical IllnessFAERS: 2US FAERS
594Cystitis-like symptomFAERS: 2US FAERS
595Depressed Level of ConsciousnessFAERS: 2US FAERS
596Depression suicidalFAERS: 2US FAERS
597Differential white blood cell count abnormalFAERS: 2US FAERS
598EczemaFAERS: 2US FAERS
599Ejection Fraction DecreasedFAERS: 2US FAERS
600Emotional disorderFAERS: 2US FAERS
601Emotional distressFAERS: 2US FAERS
602EpididymitisFAERS: 2US FAERS
603Epstein-Barr virus test positiveFAERS: 2US FAERS
604Erectile dysfunctionFAERS: 2US FAERS
605ErysipelasFAERS: 2US FAERS
606ErythroblastosisFAERS: 2US FAERS
607Escherichia pyelonephritisFAERS: 2US FAERS
608ExcoriationFAERS: 2US FAERS
609Febrile bone marrow aplasiaFAERS: 2US FAERS
610Feeling of body temperature changeFAERS: 2US FAERS
611Food AllergyFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
612Food cravingFAERS: 2US FAERS
613Frustration tolerance decreasedFAERS: 2US FAERS
614Gastrointestinal bacterial infectionFAERS: 2US FAERS
615Gastrointestinal inflammationFAERS: 2US FAERS
616General symptomFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
617Graft versus host disease in gastrointestinal tractFAERS: 2US FAERS
618Graft versus host disease in skinFAERS: 2US FAERS
619Granulocyte count increasedFAERS: 2US FAERS
620Haptoglobin DecreasedFAERS: 2US FAERS
621Hepatitis B DNA increasedFAERS: 2US FAERS
622Hip surgeryFAERS: 2US FAERS
623HyperplasiaFAERS: 2US FAERS
624Idiopathic pneumonia syndromeFAERS: 2US FAERS
625Incorrect product storageFAERS: 2US FAERS
626Intentional dose omissionFAERS: 2US FAERS
627IntertrigoFAERS: 2US FAERS
628Intra-abdominal fluid collectionFAERS: 2US FAERS
629Intracranial AneurysmFAERS: 2US FAERS
630LabyrinthitisFAERS: 2US FAERS
631Left Ventricular HypertrophyFAERS: 2US FAERS
632Ligament ruptureFAERS: 2US FAERS
633Loss of personal independence in daily activitiesFAERS: 2US FAERS
634Loss of proprioceptionFAERS: 2US FAERS
635Low density lipoprotein increasedFAERS: 2US FAERS
636Lung neoplasm surgeryFAERS: 2US FAERS
637Lyme DiseaseFAERS: 2US FAERS
638Lymph node abscessFAERS: 2US FAERS
639Manufacturing product shipping issueFAERS: 2US FAERS
640MarasmusFAERS: 2US FAERS
641Maternal exposure during pregnancyFAERS: 2US FAERS
642Megakaryocytes increasedFAERS: 2US FAERS
643MeningiomaFAERS: 2US FAERS
644MenopauseFAERS: 2US FAERS
645Mental disorder due to a general medical conditionFAERS: 2US FAERS
646Metamyelocyte count decreasedFAERS: 2US FAERS
647Metastases to stomachFAERS: 2US FAERS
648Middle insomniaFAERS: 2US FAERS
649Monocyte count increasedFAERS: 2US FAERS
650MonocytopeniaFAERS: 2US FAERS
651MonocytosisFAERS: 2US FAERS
652Mouth swellingFAERS: 2US FAERS
653Muscle tightnessFAERS: 2US FAERS
654Nasal mucosal disorderFAERS: 2US FAERS
655Nephrotic SyndromeFAERS: 2US FAERS
656Neutrophil count abnormalFAERS: 2US FAERS
657NystagmusFAERS: 2US FAERS
658Ocular icterusFAERS: 2US FAERS
659OliguriaFAERS: 2US FAERS
660Oncologic complicationFAERS: 2US FAERS
661OrchitisFAERS: 2US FAERS
662OsteorrhagiaFAERS: 2US FAERS
663OsteosclerosisFAERS: 2US FAERS
664Otitis ExternaFAERS: 2US FAERS
665Otitis MediaFAERS: 2US FAERS
666Oxygen saturation abnormalFAERS: 2US FAERS
667Oxygen saturation increasedFAERS: 2US FAERS
668Paranasal sinus mucosal hypertrophyFAERS: 2US FAERS
669ParaparesisFAERS: 2US FAERS
670PeriodontitisFAERS: 2US FAERS
671Peripheral venous diseaseFAERS: 2US FAERS
672Perirectal abscessFAERS: 2US FAERS
673Physical assaultFAERS: 2US FAERS
674Plasmablastic lymphomaFAERS: 2US FAERS
675Pneumatosis intestinalisFAERS: 2US FAERS
676PolyuriaFAERS: 2US FAERS
677Post procedural sepsisFAERS: 2US FAERS
678Post procedural swellingFAERS: 2US FAERS
679Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
680Prescribed overdoseFAERS: 2US FAERS
681Procedural complicationFAERS: 2US FAERS
682Product container seal issueFAERS: 2US FAERS
683Product difficult to swallowFAERS: 2US FAERS
684Pulmonary arterial hypertensionFAERS: 2US FAERS
685PurpuraFAERS: 2US FAERS
686Pyoderma GangrenosumFAERS: 2US FAERS
687Red blood cell analysis abnormalFAERS: 2US FAERS
688Refractory cytopenia with unilineage dysplasiaFAERS: 2US FAERS
689Restrictive pulmonary diseaseFAERS: 2US FAERS
690RetchingFAERS: 2US FAERS
691Reticulocyte count decreasedFAERS: 2US FAERS
692RetinitisFAERS: 2US FAERS
693Retroperitoneal lymphadenopathyFAERS: 2US FAERS
694RhabdomyolysisFAERS: 2US FAERS
695Rhinovirus infectionFAERS: 2US FAERS
696Rotator cuff syndromeFAERS: 2US FAERS
697ShockFAERS: 2US FAERS
698Skin graft infectionFAERS: 2US FAERS
699Skin squamous cell carcinoma recurrentFAERS: 2US FAERS
700SluggishnessFAERS: 2US FAERS
701Sodium retentionFAERS: 2US FAERS
702Soft Tissue InfectionFAERS: 2US FAERS
703Splenic necrosisFAERS: 2US FAERS
704Splenic thrombosisFAERS: 2US FAERS
705Staphylococcal abscessFAERS: 2US FAERS
706Stevens-Johnson SyndromeFAERS: 2US FAERS
707Subdural EffusionFAERS: 2US FAERS
708SunburnFAERS: 2US FAERS
709Therapeutic response changedFAERS: 2US FAERS
710ThirstFAERS: 2US FAERS
711Tongue discomfortFAERS: 2US FAERS
712Transplantation complicationFAERS: 2US FAERS
713TrichophytosisFAERS: 2US FAERS
714Trigeminal NeuralgiaFAERS: 2US FAERS
715Typhoid FeverFAERS: 2US FAERS
716Urine output increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
717Uterine CancerFAERS: 2US FAERS
718Varicella Zoster Virus InfectionFAERS: 2US FAERS
719Vascular compressionFAERS: 2US FAERS
720Venous ThrombosisFAERS: 2US FAERS
721Vessel perforationFAERS: 2US FAERS
722Vulvovaginal rashFAERS: 2US FAERS
723White matter lesionFAERS: 2US FAERS
724Wrong drug administeredFAERS: 2US FAERS
725Abdominal AbscessFAERS: 1US FAERS
726Abdominal sepsisFAERS: 1US FAERS
727Abdominal symptomFAERS: 1US FAERS
728Abdominal tendernessFAERS: 1US FAERS
729Accidental deathFAERS: 1US FAERS
730Accidental exposure to product by childFAERS: 1US FAERS
731AgranulocytosisFAERS: 1US FAERS
732Aicardi's syndromeFAERS: 1US FAERS
733Alcohol IntoleranceFAERS: 1US FAERS
734Allergic respiratory symptomFAERS: 1US FAERS
735Allergic sinusitisFAERS: 1US FAERS
736Ammonia increasedFAERS: 1US FAERS
737Amyotrophic Lateral SclerosisFAERS: 1US FAERS
738Anal FissureFAERS: 1US FAERS
739AneurysmFAERS: 1US FAERS
740AngioedemaFAERS: 1US FAERS
741Animal biteFAERS: 1US FAERS
742Anorectal discomfortFAERS: 1US FAERS
743Antiphospholipid SyndromeFAERS: 1US FAERS
744Aphthous StomatitisFAERS: 1US FAERS
745AppendicolithFAERS: 1US FAERS
746Aquagenic pruritusFAERS: 1US FAERS
747ArteriosclerosisFAERS: 1US FAERS
748Arthropod stingFAERS: 1US FAERS
749AsphyxiaFAERS: 1US FAERS
750AsthenopiaFAERS: 1US FAERS
751Asymptomatic viral hepatitisFAERS: 1US FAERS
752AuraFAERS: 1US FAERS
753Autoimmune thyroiditisFAERS: 1US FAERS
754Autonomic nervous system imbalanceFAERS: 1US FAERS
755Avulsion fractureFAERS: 1US FAERS
756BacteriuriaFAERS: 1US FAERS
757Band neutrophil count increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
758Base excess increasedFAERS: 1US FAERS
759Basophil count abnormalFAERS: 1US FAERS
760Biliary dilatationFAERS: 1US FAERS
761Biopsy bone marrow abnormalFAERS: 1US FAERS
762BiopsyFAERS: 1US FAERS
763BlepharitisFAERS: 1US FAERS
764Blood bilirubin decreasedFAERS: 1US FAERS
765Blood calcium abnormalFAERS: 1US FAERS
766Blood chloride increasedFAERS: 1US FAERS
767Blood creatinine abnormalFAERS: 1US FAERS
768Blood electrolytes increasedFAERS: 1US FAERS
769Blood erythropoietin decreasedFAERS: 1US FAERS
770Blood erythropoietin increasedFAERS: 1US FAERS
771Blood fibrinogen increasedFAERS: 1US FAERS
772Blood folate decreasedFAERS: 1US FAERS
773Blood lactate dehydrogenase decreasedFAERS: 1US FAERS
774Blood magnesium decreasedFAERS: 1US FAERS
775Blood phosphorus abnormalFAERS: 1US FAERS
776Blood pressure fluctuationFAERS: 1US FAERS
777Blood testosterone decreasedFAERS: 1US FAERS
778Blood uric acid abnormalFAERS: 1US FAERS
779Bone abscessFAERS: 1US FAERS
780Bone density decreasedFAERS: 1US FAERS
781Bone marrow necrosisFAERS: 1US FAERS
782BradykinesiaFAERS: 1US FAERS
783BradyphreniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
784Brain natriuretic peptide increasedFAERS: 1US FAERS
785Brain stem syndromeFAERS: 1US FAERS
786Breast cancer recurrentFAERS: 1US FAERS
787Breast tendernessFAERS: 1US FAERS
788BronchiectasisFAERS: 1US FAERS
789Burning feet syndromeFAERS: 1US FAERS
790C-reactive protein decreasedFAERS: 1US FAERS
791Campylobacter colitisFAERS: 1US FAERS
792Candida pneumoniaFAERS: 1US FAERS
793Carbon dioxide increasedFAERS: 1US FAERS
794Cardiac FlutterFAERS: 1US FAERS
795Cardiac HypertrophyFAERS: 1US FAERS
796Cardiac autonomic neuropathyFAERS: 1US FAERS
797Cardiac infectionFAERS: 1US FAERS
798Central nervous system lesionFAERS: 1US FAERS
799Cerebral PalsyFAERS: 1US FAERS
800Cerebral disorderFAERS: 1US FAERS
801CheilitisFAERS: 1US FAERS
802ChemotherapyFAERS: 1US FAERS
803ChoroiditisFAERS: 1US FAERS
804Chronic graft versus host disease in liverFAERS: 1US FAERS
805Chronic graft versus host disease in skinFAERS: 1US FAERS
806Chronic sinusitisFAERS: 1US FAERS
807Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
808Citrobacter sepsisFAERS: 1US FAERS
809Clonal EvolutionFAERS: 1US FAERS
810ClonusFAERS: 1US FAERS
811Coagulation test abnormalFAERS: 1US FAERS
812Coma scale abnormalFAERS: 1US FAERS
813Congenital thrombocyte disorderFAERS: 1US FAERS
814Contrast media reactionFAERS: 1US FAERS
815Conversion disorderFAERS: 1US FAERS
816Coombs test positiveFAERS: 1US FAERS
817Cor pulmonaleFAERS: 1US FAERS
818Corneal InfectionFAERS: 1US FAERS
819Corneal PerforationFAERS: 1US FAERS
820Corneal ScarFAERS: 1US FAERS
821Creatinine renal clearance increasedFAERS: 1US FAERS
822Cryptococcus test positiveFAERS: 1US FAERS
823Cystitis viralFAERS: 1US FAERS
824CystoscopyFAERS: 1US FAERS
825Cytokine abnormalFAERS: 1US FAERS
826Cytology abnormalFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
827Cytomegalovirus test positiveFAERS: 1US FAERS
828Dark circles under eyesFAERS: 1US FAERS
829DeformityFAERS: 1US FAERS
830DemyelinationFAERS: 1US FAERS
831DependenceFAERS: 1US FAERS
832Dermo-hypodermitisFAERS: 1US FAERS
833Device dependenceFAERS: 1US FAERS
834Device dislocationFAERS: 1US FAERS
835Device related infectionFAERS: 1US FAERS
836Diabetic RetinopathyFAERS: 1US FAERS
837Diastolic dysfunctionFAERS: 1US FAERS
838Diastolic hypertensionFAERS: 1US FAERS
839Diffuse alopeciaFAERS: 1US FAERS
840Disease susceptibilityFAERS: 1US FAERS
841Diuretic therapyFAERS: 1US FAERS
842Diverticular perforationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
843Drug DependenceFAERS: 1US FAERS
844Drug effective for unapproved indicationFAERS: 1US FAERS
845Drug level increasedFAERS: 1US FAERS
846Drug specific antibody presentFAERS: 1US FAERS
847DyscheziaFAERS: 1US FAERS
848DysenteryFAERS: 1US FAERS
849DysponesisFAERS: 1US FAERS
850Eating disorder symptomFAERS: 1US FAERS
851Economic problemFAERS: 1US FAERS
852Electrocardiogram abnormalFAERS: 1US FAERS
853Electrocardiogram changeFAERS: 1US FAERS
854Embolic strokeFAERS: 1US FAERS
855Emergency care examinationFAERS: 1US FAERS
856EnteritisFAERS: 1US FAERS
857Enterococcal infectionFAERS: 1US FAERS
858EnuresisFAERS: 1US FAERS
859Enzyme abnormalityFAERS: 1US FAERS
860Enzyme level increasedFAERS: 1US FAERS
861EpicondylitisFAERS: 1US FAERS
862Epidermal necrosisFAERS: 1US FAERS
863Epidural lipomatosisFAERS: 1US FAERS
864Epigastric discomfortFAERS: 1US FAERS
865EpiglottitisFAERS: 1US FAERS
866Epstein-Barr virus antibody positiveFAERS: 1US FAERS
867Erythema NodosumFAERS: 1US FAERS
868Erythroblast count abnormalFAERS: 1US FAERS
869ErythromelalgiaFAERS: 1US FAERS
870Exposure to body fluidFAERS: 1US FAERS
871Exposure via body fluidFAERS: 1US FAERS
872Exposure via skin contactFAERS: 1US FAERS
873Factor XI DeficiencyFAERS: 1US FAERS
874Fanconi SyndromeFAERS: 1US FAERS
875Fear of fallingFAERS: 1US FAERS
876Feeding tube userFAERS: 1US FAERS
877FibromyalgiaFAERS: 1US FAERS
878FormicationFAERS: 1US FAERS
879Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
880GangreneFAERS: 1US FAERS
881Gas GangreneFAERS: 1US FAERS
882Gastric mucosal lesionFAERS: 1US FAERS
883Gastrointestinal bacterial overgrowthFAERS: 1US FAERS
884Gastrointestinal candidiasisFAERS: 1US FAERS
885Gastrointestinal motility disorderFAERS: 1US FAERS
886Gastrointestinal perforationFAERS: 1US FAERS
887Gastrointestinal sounds abnormalFAERS: 1US FAERS
888Gastrointestinal toxicityFAERS: 1US FAERS
889Gastrointestinal viral infectionFAERS: 1US FAERS
890Gastrointestinal wall thickeningFAERS: 1US FAERS
891Gastrooesophageal cancerFAERS: 1US FAERS
892Gelatinous transformation of the bone marrowFAERS: 1US FAERS
893Gene MutationFAERS: 1US FAERS
894General physical condition decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
895Genital infection fungalFAERS: 1US FAERS
896Genital labial operationFAERS: 1US FAERS
897GiardiasisFAERS: 1US FAERS
898GlioblastomaFAERS: 1US FAERS
899GlomerulonephritisFAERS: 1US FAERS
900Graft lossFAERS: 1US FAERS
901Graft versus host disease in eyeFAERS: 1US FAERS
902Granulocytes maturation arrestFAERS: 1US FAERS
903HER-2 positive breast cancerFAERS: 1US FAERS
904Heart sounds abnormalFAERS: 1US FAERS
905Hepatic vascular thrombosisFAERS: 1US FAERS
906Hepatic vein occlusionFAERS: 1US FAERS
907Hepatitis B core antibody positiveFAERS: 1US FAERS
908Hepatitis B surface antigen positiveFAERS: 1US FAERS
909Hepatitis B virus test positiveFAERS: 1US FAERS
910Hepatopulmonary SyndromeFAERS: 1US FAERS
911Herpes simplex serology positiveFAERS: 1US FAERS
912Herpes zoster infection neurologicalFAERS: 1US FAERS
913Hormone level abnormalFAERS: 1US FAERS
914HypercapniaFAERS: 1US FAERS
915Hypereosinophilic syndromeFAERS: 1US FAERS
916HyperleukocytosisFAERS: 1US FAERS
917HyperparathyroidismFAERS: 1US FAERS
918HyperpyrexiaFAERS: 1US FAERS
919HypervigilanceFAERS: 1US FAERS
920Hyperviscosity syndromeFAERS: 1US FAERS
921HypobarismFAERS: 1US FAERS
922HypohidrosisFAERS: 1US FAERS
923HypoparathyroidismFAERS: 1US FAERS
924Iatrogenic injuryFAERS: 1US FAERS
925Illness anxiety disorderFAERS: 1US FAERS
926Immunoglobulin TherapyFAERS: 1US FAERS
927Impaired gastric emptyingFAERS: 1US FAERS
928Impaired quality of lifeFAERS: 1US FAERS
929Incision site infectionFAERS: 1US FAERS
930Incisional herniaFAERS: 1US FAERS
931IncoherentFAERS: 1US FAERS
932Incorrect drug dosage form administeredFAERS: 1US FAERS
933Increased upper airway secretionFAERS: 1US FAERS
934Increased viscosity of upper respiratory secretionFAERS: 1US FAERS
935Infected dermal cystFAERS: 1US FAERS
936Infection reactivationFAERS: 1US FAERS
937Infectious pleural effusionFAERS: 1US FAERS
938Infrequent bowel movementsFAERS: 1US FAERS
939Inguinal massFAERS: 1US FAERS
940Initial insomniaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
941Injection site bruisingFAERS: 1US FAERS
942Injection site phlebitisFAERS: 1US FAERS
943Insurance issueFAERS: 1US FAERS
944Intellectual DisabilityFAERS: 1US FAERS
945Intervertebral Disc DegenerationFAERS: 1US FAERS
946Intestinal congestionFAERS: 1US FAERS
947Invasive Ductal Breast CarcinomaFAERS: 1US FAERS
948Investigation abnormalFAERS: 1US FAERS
949Klebsiella sepsisFAERS: 1US FAERS
950Klebsiella test positiveFAERS: 1US FAERS
951Large intestine erosionFAERS: 1US FAERS
952Leukocytoclastic vasculitisFAERS: 1US FAERS
953Leukotriene increasedFAERS: 1US FAERS
954Libido disorderFAERS: 1US FAERS
955Ligament painFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
956Lip and/or oral cavity cancerFAERS: 1US FAERS
957Lip exfoliationFAERS: 1US FAERS
958LipomaFAERS: 1US FAERS
959Liposarcoma recurrentFAERS: 1US FAERS
960ListeriosisFAERS: 1US FAERS
961Liver function test decreasedFAERS: 1US FAERS
962Loose toothFAERS: 1US FAERS
963Lung carcinoma cell type unspecified stage IFAERS: 1US FAERS
964Lung consolidationFAERS: 1US FAERS
965Lung perforationFAERS: 1US FAERS
966Lymph nodes scan abnormalFAERS: 1US FAERS
967LymphangitisFAERS: 1US FAERS
968Lymphocyte count abnormalFAERS: 1US FAERS
969MacrocytosisFAERS: 1US FAERS
970MalabsorptionFAERS: 1US FAERS
971Mantle cell lymphoma recurrentFAERS: 1US FAERS
972Mantle cell lymphomaFAERS: 1US FAERS
973Mastication disorderFAERS: 1US FAERS
974MastocytosisFAERS: 1US FAERS
975Medial Tibial Stress SyndromeFAERS: 1US FAERS
976Mediastinal massFAERS: 1US FAERS
977Meningitis herpesFAERS: 1US FAERS
978Mesenteric vascular insufficiencyFAERS: 1US FAERS
979Metabolic acidosisFAERS: 1US FAERS
980Metapneumovirus infectionFAERS: 1US FAERS
981Metastases to salivary glandFAERS: 1US FAERS
982MetatarsalgiaFAERS: 1US FAERS
983Micturition frequency decreasedFAERS: 1US FAERS
984Mole excisionFAERS: 1US FAERS
985Motion SicknessFAERS: 1US FAERS
986Multiple SclerosisFAERS: 1US FAERS
987Multiple drug therapyFAERS: 1US FAERS
988Muscle RigidityFAERS: 1US FAERS
989Muscle abscessFAERS: 1US FAERS
990Mutagenic effectFAERS: 1US FAERS
991Myasthenia GravisFAERS: 1US FAERS
992Mycobacterium abscessus InfectionFAERS: 1US FAERS
993Mycobacterium tuberculosis complex test positiveFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
994Mycosis FungoidesFAERS: 1US FAERS
995MydriasisFAERS: 1US FAERS
996Myeloblast count increasedFAERS: 1US FAERS
997Myeloblast presentFAERS: 1US FAERS
998MyelocytosisFAERS: 1US FAERS
999Myocardial necrosisFAERS: 1US FAERS
1000MyopathyFAERS: 1US FAERS
1001N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
1002NarcolepsyFAERS: 1US FAERS
1003Nasal herpesFAERS: 1US FAERS
1004NephrosclerosisFAERS: 1US FAERS
1005Nerve injuryFAERS: 1US FAERS
1006Neurological decompensationFAERS: 1US FAERS
1007Neurological examination abnormalFAERS: 1US FAERS
1008Neuromyelitis OpticaFAERS: 1US FAERS
1009Neutrophil percentage decreasedFAERS: 1US FAERS
1010Nodular rashFAERS: 1US FAERS
1011Nodular vasculitisFAERS: 1US FAERS
1012Non-Hodgkin's lymphoma unspecified histology indolentFAERS: 1US FAERS
1013Non-cardiac chest painFAERS: 1US FAERS
1014ObesityFAERS: 1US FAERS
1015Obsessive-Compulsive DisorderFAERS: 1US FAERS
1016Occult blood positiveFAERS: 1US FAERS
1017Ocular discomfortFAERS: 1US FAERS
1018OnychalgiaFAERS: 1US FAERS
1019Optic NeuritisFAERS: 1US FAERS
1020Oral infectionFAERS: 1US FAERS
1021Oral mucosal exfoliationFAERS: 1US FAERS
1022Oral pruritusFAERS: 1US FAERS
1023Orgasmic sensation decreasedFAERS: 1US FAERS
1024Osmotic demyelination syndromeFAERS: 1US FAERS
1025OsteochondrosisFAERS: 1US FAERS
1026Osteonecrosis of JawFAERS: 1US FAERS
1027OsteoradionecrosisFAERS: 1US FAERS
1028Overlap syndromeFAERS: 1US FAERS
1029Pancreatic enzymes increasedFAERS: 1US FAERS
1030PapillomaFAERS: 1US FAERS
1031PapuleFAERS: 1US FAERS
1032Paranasal sinus hypersecretionFAERS: 1US FAERS
1033ParanoiaFAERS: 1US FAERS
1034Parasitic gastroenteritisFAERS: 1US FAERS
1035Paternal exposure during pregnancyFAERS: 1US FAERS
1036Pathological fractureFAERS: 1US FAERS
1037Pelvic PainFAERS: 1US FAERS
1038Penile swellingFAERS: 1US FAERS
1039PeriostitisFAERS: 1US FAERS
1040Peripheral artery occlusionFAERS: 1US FAERS
1041Personality ChangeFAERS: 1US FAERS
1042PhotophobiaFAERS: 1US FAERS
1043Physical disabilityFAERS: 1US FAERS
1044Physical product label issueFAERS: 1US FAERS
1045Platelet dysfunctionFAERS: 1US FAERS
1046Platelet function test abnormalFAERS: 1US FAERS
1047PneumobiliaFAERS: 1US FAERS
1048Pneumococcal sepsisFAERS: 1US FAERS
1049PneumoperitoneumFAERS: 1US FAERS
1050PoisoningFAERS: 1US FAERS
1051Polymerase Chain ReactionFAERS: 1US FAERS
1052PolyserositisFAERS: 1US FAERS
1053Poor personal hygieneFAERS: 1US FAERS
1054Poor quality drug administeredFAERS: 1US FAERS
1055Portal vein pressure increasedFAERS: 1US FAERS
1056Portal venous gasFAERS: 1US FAERS
1057Positron emission tomogram abnormalFAERS: 1US FAERS
1058Post procedural contusionFAERS: 1US FAERS
1059Post procedural dischargeFAERS: 1US FAERS
1060Post procedural pneumoniaFAERS: 1US FAERS
1061Post-traumatic painFAERS: 1US FAERS
1062Poverty of speechFAERS: 1US FAERS
1063Pre-existing condition improvedFAERS: 1US FAERS
1064Pregnancy of partnerFAERS: 1US FAERS
1065Prescribed underdoseFAERS: 1US FAERS
1066Procalcitonin increasedFAERS: 1US FAERS
1067Product blister packaging issueFAERS: 1US FAERS
1068Product label issueFAERS: 1US FAERS
1069Product packaging issueFAERS: 1US FAERS
1070Product supply issueFAERS: 1US FAERS
1071Promyelocyte count increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1072Prostatitis Escherichia coliFAERS: 1US FAERS
1073Pruritus allergicFAERS: 1US FAERS
1074PseudarthrosisFAERS: 1US FAERS
1075Psoas AbscessFAERS: 1US FAERS
1076Pulmonary necrosisFAERS: 1US FAERS
1077Pulmonary painFAERS: 1US FAERS
1078Pulmonary renal syndromeFAERS: 1US FAERS
1079Pulmonary toxicityFAERS: 1US FAERS
1080Pulmonary venous thrombosisFAERS: 1US FAERS
1081Puncture site bruiseFAERS: 1US FAERS
1082PurulenceFAERS: 1US FAERS
1083PyelocaliectasisFAERS: 1US FAERS
1084Pyruvate kinase increasedFAERS: 1US FAERS
1085Radiation neuropathyFAERS: 1US FAERS
1086Radiation proctitisFAERS: 1US FAERS
1087Radicular painFAERS: 1US FAERS
1088Rectal fissureFAERS: 1US FAERS
1089Refractory cytopenia with multilineage dysplasiaFAERS: 1US FAERS
1090Rehabilitation therapyFAERS: 1US FAERS
1091Renal Cell CarcinomaFAERS: 1US FAERS
1092Renal ColicFAERS: 1US FAERS
1093Renal aneurysmFAERS: 1US FAERS
1094Renal cancer metastaticFAERS: 1US FAERS
1095Renal massFAERS: 1US FAERS
1096Renal vein compressionFAERS: 1US FAERS
1097Reproductive tract anastomotic leakFAERS: 1US FAERS
1098ReticulocytosisFAERS: 1US FAERS
1099Retinal Vascular DisorderFAERS: 1US FAERS
1100Retinal Vein OcclusionFAERS: 1US FAERS
1101Retinal pigment epitheliopathyFAERS: 1US FAERS
1102Rheumatic Heart DiseaseFAERS: 1US FAERS
1103Right ventricular failureFAERS: 1US FAERS
1104Salmonella sepsisFAERS: 1US FAERS
1105SarcomaFAERS: 1US FAERS
1106Scedosporium infectionFAERS: 1US FAERS
1107Schizoaffective DisorderFAERS: 1US FAERS
1108SeminomaFAERS: 1US FAERS
1109SerositisFAERS: 1US FAERS
1110Serum sickness-like reactionFAERS: 1US FAERS
1111Sinus TachycardiaFAERS: 1US FAERS
1112Sinus bradycardiaFAERS: 1US FAERS
1113Sinus painFAERS: 1US FAERS
1114Sinusitis aspergillusFAERS: 1US FAERS
1115Skin discomfortFAERS: 1US FAERS
1116Skin test positiveFAERS: 1US FAERS
1117Skin tightnessFAERS: 1US FAERS
1118Solar dermatitisFAERS: 1US FAERS
1119Somatoform DisorderFAERS: 1US FAERS
1120Spinal column injuryFAERS: 1US FAERS
1121Spinal column stenosisFAERS: 1US FAERS
1122Spleen palpableFAERS: 1US FAERS
1123Splenic abscessFAERS: 1US FAERS
1124Splenic varicesFAERS: 1US FAERS
1125Splenic vein thrombosisFAERS: 1US FAERS
1126Squamous cell carcinoma of lungFAERS: 1US FAERS
1127StarvationFAERS: 1US FAERS
1128Streptococcal endocarditisFAERS: 1US FAERS
1129Stress ulcerFAERS: 1US FAERS
1130StridorFAERS: 1US FAERS
1131Superinfection bacterialFAERS: 1US FAERS
1132SuperinfectionFAERS: 1US FAERS
1133Supraventricular tachycardiaFAERS: 1US FAERS
1134Swelling of eyelidFAERS: 1US FAERS
1135Synovial CystFAERS: 1US FAERS
1136Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1137Systemic mycosisFAERS: 1US FAERS
1138Temperature intoleranceFAERS: 1US FAERS
1139Therapeutic procedureFAERS: 1US FAERS
1140Therapeutic product effect decreasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1141Thermal burnFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1142Tongue cancer recurrentFAERS: 1US FAERS
1143Tongue eruptionFAERS: 1US FAERS
1144Total lung capacity increasedFAERS: 1US FAERS
1145Toxic Epidermal NecrolysisFAERS: 1US FAERS
1146Toxic anterior segment syndromeFAERS: 1US FAERS
1147Tracheal StenosisFAERS: 1US FAERS
1148Transaminases abnormalFAERS: 1US FAERS
1149Transfusion ReactionFAERS: 1US FAERS
1150Trichophytic granulomaFAERS: 1US FAERS
1151TrichorrhexisFAERS: 1US FAERS
1152UnderweightFAERS: 1US FAERS
1153Upper motor neurone lesionFAERS: 1US FAERS
1154Urinary tract infection viralFAERS: 1US FAERS
1155Urinary tract obstructionFAERS: 1US FAERS
1156Urine flow decreasedFAERS: 1US FAERS
1157Urticaria PigmentosaFAERS: 1US FAERS
1158Uterine ProlapseFAERS: 1US FAERS
1159UveitisFAERS: 1US FAERS
1160VIIth nerve paralysisFAERS: 1US FAERS
1161Vaginal DischargeFAERS: 1US FAERS
1162Varicella virus test positiveFAERS: 1US FAERS
1163Vascular occlusionFAERS: 1US FAERS
1164Vascular ruptureFAERS: 1US FAERS
1165Vascular stent stenosisFAERS: 1US FAERS
1166Venoocclusive diseaseFAERS: 1US FAERS
1167Venous aneurysmFAERS: 1US FAERS
1168Venous occlusionFAERS: 1US FAERS
1169Vertebral foraminal stenosisFAERS: 1US FAERS
1170Vertebral lesionFAERS: 1US FAERS
1171Vessel puncture site bruiseFAERS: 1US FAERS
1172Viral pharyngitisFAERS: 1US FAERS
1173Visceral venous thrombosisFAERS: 1US FAERS
1174Vitreous injuryFAERS: 1US FAERS
1175Vulvovaginal discomfortFAERS: 1US FAERS
1176Vulvovaginal mycotic infectionFAERS: 1US FAERS
1177Vulvovaginal pruritusFAERS: 1US FAERS
1178West Nile viral infectionFAERS: 1US FAERS
1179Wheelchair userFAERS: 1US FAERS
1180Wound abscessFAERS: 1US FAERS
1181Wrong doseFAERS: 1US FAERS
1182XanthomaFAERS: 1US FAERS
1183Zika Virus InfectionFAERS: 1US FAERS
1184ZygomycosisFAERS: 1US FAERS
1185carbuncleFAERS: 1US FAERS
1186keratoacanthomaFAERS: 1US FAERS
1187liposarcomaFAERS: 1US FAERS
1188General physical conditionCanada Vigilance: 1Canada Vigilance
1189Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
1190Red blood cell nucleated morphology presentCanada Vigilance: 1Canada Vigilance
1191Therapeutic product effect delayedCanada Vigilance: 1Canada Vigilance
1192Up and down phenomenonCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.